Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)

Li Shao,Jing Liu,Yu Song,Wenjun Yang,Ling Gong,Zhe Lyu,Qianru Zhu,Jinlong Fu,Jie Li,Junping Shi
DOI: https://doi.org/10.1016/j.cca.2022.12.014
IF: 6.314
2022-01-01
Clinica Chimica Acta
Abstract:•Mitochondrial dysfunction, destructed phospholipids homeostasis, and folate deficiency were most severe in MAFLD concurrent T2DM patients.•Formiminoglutamate, sphinganine and sphingosine correlated positively with HbA1c, while glycoursodeoxycholicacidsulfate correlated positively with AST.•The linear discriminant analysis (LDA) model using metabolites 5-hydroxyhexanoate, ribitol and formiminoglutamate demonstrated pretty good performance in screening for MAFLD patients.
What problem does this paper attempt to address?